1. Golubnitschaja O, Costigliola V, EPMA. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2012;3(1):14. doi: 10.1186/1878-5085-3-14 .
2. Grech G, Zhan X, Yoo BC, Bubnov R, Hagan S, Danesi R, et al. EPMA position paper in cancer: current overview and future perspectives. EPMA J. 2015;6:9. doi: 10.1186/s13167-015-0030-6 .
3. Chow IP, Bryant T, Swanson S, Schoeninger B. Dissecting the value of companion diagnostics. IMS Consulting Group. 2013. Accessed from http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Healthcare/IMS%20Consulting/Our%20Latest%20Thinking/Q1_2013_IMSCG_Market_Access_Conference_Dissecting_The_Value_of_CDx_07_Mar2013.pdf on May 18, 2015.
4. Carson J. Molecular methods rapidly gain ground in infectious disease diagnostics. Frost & Sullivan. 2014. Accessed from http://ww2.frost.com/news/press-releases/molecular-methodsrapidly-gain-ground-infectious-disease-diagnostics-says-frost-sullivan/ on May 17, 2015.
5. NCBI. GTR: Genetic Testing Registry. NCBI. 2015. Accessed from http://www.ncbi.nlm.nih.gov/gtr/ on May 29, 2015.